Decrease of B16F0 melanoma cells via downregulation of Ras-related C3 botulinum toxin substrate 1 (Rac1) and Wiskott–Aldrich syndrome protein family member 2 (WAVE2). This evidence concerns the gene RAC1 and melanoma.